title: Efficacy of beta radiation in prevention of post-angioplasty restenosis. An interim report from the beta energy restenosis trial.
abstract: Restenosis remains a major limitation of coronary angioplasty in spite of major advances in techniques and technology. Recent studies have demonstrated that ionizing radiation may limit the degree of this problem. Gamma radiation has been shown to be effective in reducing in stent restenosis in humans, and beta radiation following encouraging results in animals has been shown to be feasible in humans. The objective of this study was to assess the feasibility of a 5 F non-centered catheter to deliver beta radiation emitting seeds to the lesion site post angioplasty and its effect on restenosis. Following successful angioplasty, patients were randomized to treatment with 12, 14 or 16 Gy at the angioplasty site. This was delivered with a 5 F non-centered catheter. Twelve beta radiation emitting seeds (90Sr/Y) were delivered to an area 3 cm in length to cover the angioplasty site. Angiographic follow-up was performed at 6 months. Baseline and follow-up angiograms were performed by blinded investigators at a core laboratory. This interim report comprises the first 35 patients to complete 6-month angiographic follow-up. There were no major radiation incidents. Four patients had evidence of angiographic restenosis. The MLD (mm) and percent stenosis were 0.77 +/- 0.27/72.5 +/- 8.6 pre angioplasty, 2.08 +/- 0.4/25.7 +/- 9.8 post angioplasty and radiation and 2.05 +/- 0.59/25.7 +/- 19.8 at follow-up respectively.
  
  
  CONCLUSIONS
  Beta radiation can be feasibly and safely delivered post coronary angioplasty with a very encouraging reduction of restenosis.
authors.affiliation: Institut de Cardiologie de Montréal, Québec, Canada.
authors.forename: D
authors.initials: D
authors.lastname: Meerkin
authors.forename: R
authors.initials: R
authors.lastname: Bonan
authors.forename: I R
authors.initials: IR
authors.lastname: Crocker
authors.forename: A
authors.initials: A
authors.lastname: Arsenault
authors.forename: P
authors.initials: P
authors.lastname: Chougule
authors.forename: V
authors.initials: V
authors.lastname: Coen
authors.forename: D O
authors.initials: DO
authors.lastname: Williams
authors.forename: P
authors.initials: P
authors.lastname: Serruys
authors.forename: S B
authors.initials: SB
authors.lastname: King
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation*; D001610:Beta Particles; D001918:Brachytherapy / Q000295:instrumentation*; D003131:Combined Modality Therapy; D017023:Coronary Angiography; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D004867:Equipment Design; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D016896:Treatment Outcome